Table 1.
Demographic characteristics, etiology, and clinical staging of NVG patients
| Parameter | n (%) / Mean ± Standard Deviation (Range) |
|---|---|
| Number of eyes | 90 |
| Number of patients | 81 |
| Sex | |
| — Female | 25 (30.8%) |
| — Male | 56 (69.2%) |
| Laterality | |
| — Right eye | 48 (53.3%) |
| — Left eye | 42 (46.7%) |
| Age (years) | 65.47 ± 10.06 (38–92) |
| Etiology of NVG | |
| — DR | 60 (66.7%) |
| — CRVO | 23 (26.7%) |
| — BRVO | 2 (2.2%) |
| — RAO | 2 (2.2%) |
| — Ocular Trauma | 1 (1.1%) |
| — CRRD | 1 (1.1%) |
| NVG Stage at Presentation | |
| — Stage 2 (Rubeosis Iridis (Early Stage)) | 21 (23.3%) |
| — Stage 3 (Open-angle glaucoma) | 54 (60.0%) |
| — Stage 4 (Angle-closure glaucoma) | 15 (16.7%) |
BRVO: Branch retinal vein occlusion; CRVO: Central retinal vein occlusion; DR: Diabetic retinopathy; NVG: Neovascular glaucoma; RAO: Retinal artery occlusion; CRRD: Chronic rhegmatogenous retinal detachment;
* Stage 1 (Pre Rubeosis) patients were excluded from the study because they did not have any presenting complaints and did not have any anterior segment findings that could be detected during routine examination